MCRB1EUR

Seres Therapeutics, Inc.

A biotech company that makes medicines from live bacteria to restore the trillions of microbes living in the human gut. Its flagship product, VOWST, is an oral capsule approved to prevent repeat C. difficile infections. Founded in 2010 in Cambridge, Massachusetts, the company takes its name from the word "serendipity" — a nod to the lucky discoveries behind its science.

Recent Activity

Show $

2021Q4

2 sells

ARK Genomic Revolution ETFEXIT

-2.45M shares

ARK Genomic Revolution ETFEXIT

-2.45M shares

ARK Innovation ETFEXIT

-3.72M shares

ARK Innovation ETFEXIT

-3.72M shares

2021Q3

3 sells

ARK Genomic Revolution ETFTRIM

-464.8K shares(-16.0%)

ARK Genomic Revolution ETFTRIM

-464.8K shares(-16.0%)

ARK Innovation ETFTRIM

-2.84M shares(-43.3%)

ARK Innovation ETFTRIM

-2.84M shares(-43.3%)

ARK InvestEXIT

-9.71M shares

ARK InvestEXIT

-9.71M shares

2021Q2

3 sells

ARK Genomic Revolution ETFTRIM

-600.2K shares(-17.1%)

ARK Genomic Revolution ETFTRIM

-600.2K shares(-17.1%)

ARK Innovation ETFTRIM

-1.42M shares(-17.8%)

ARK Innovation ETFTRIM

-1.42M shares(-17.8%)

ARK InvestTRIM

-2.14M shares(-18.1%)

ARK InvestTRIM

-2.14M shares(-18.1%)

2021Q1

1 buy2 sells

ARK Genomic Revolution ETFADD

+139.9K shares(+4.1%)

ARK Genomic Revolution ETFADD

+139.9K shares(+4.1%)

ARK Innovation ETFTRIM

-585.3K shares(-6.8%)

ARK Innovation ETFTRIM

-585.3K shares(-6.8%)

ARK InvestTRIM

-1.89M shares(-13.7%)

ARK InvestTRIM

-1.89M shares(-13.7%)

Loading more activity...